CUYRF(CUYRF)
CUYRF
No analyst ratings available
No analyst price targets available for CUYRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $100.92B | $109.95B | $125.27B | $145.54B | $162.75B |
| Low | $99.04B | $105.15B | $121.31B | $140.93B | $157.59B |
| High | $104.50B | $114.46B | $130.08B | $151.12B | $168.99B |
| EBITDA Avg | $32.55B | $35.46B | $40.41B | $46.95B | $52.50B |
| Low | $31.95B | $33.92B | $39.13B | $45.46B | $50.83B |
| High | $33.71B | $36.92B | $41.96B | $48.75B | $54.51B |
| EBIT Avg | $29.76B | $32.42B | $36.94B | $42.91B | $47.99B |
| Low | $29.20B | $31.00B | $35.77B | $41.55B | $46.47B |
| High | $30.81B | $33.75B | $38.36B | $44.56B | $49.83B |
| Net Income Avg | $16.65B | $19.40B | $22.45B | — | — |
| Low | $15.97B | $18.60B | $21.53B | — | — |
| High | $17.49B | $20.37B | $23.57B | — | — |
| EPS Avg | $1032.43 | $1202.79 | $1391.72 | — | — |
| Low | $989.91 | $1153.25 | $1334.40 | — | — |
| High | $1083.91 | $1262.77 | $1461.12 | — | — |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 2 / 1 | 1 / — | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $25.39B | $26.18B | $27.26B |
| Low | $24.90B | $25.68B | $26.74B |
| High | $25.88B | $26.69B | $27.79B |
| EBITDA Avg | $8.19B | $8.45B | $8.79B |
| Low | $8.03B | $8.28B | $8.63B |
| High | $8.35B | $8.61B | $8.96B |
| EBIT Avg | $7.49B | $7.72B | $8.04B |
| Low | $7.34B | $7.57B | $7.88B |
| High | $7.63B | $7.87B | $8.19B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 1 / — | 1 / — |